{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:06:44Z","timestamp":1792048004989,"version":"4.4.0"},"reference-count":198,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>From a detailed review of 90 experimental and clinical metabolomic investigations of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), we have developed metabolomic hallmarks for both obesity and MASLD. Obesity studies were conducted in mice, rats, and humans, with consensus biomarker groups in plasma\/serum being essential and nonessential amino acids, energy metabolites, gut microbiota metabolites, acylcarnitines and lysophosphatidylcholines (LPC), which formed the basis of the six metabolomic hallmarks of obesity. Additionally, mice and rats shared elevated cholesterol, humans and rats shared elevated fatty acids, and humans and mice shared elevated VLDL\/LDL, bile acids and phosphatidylcholines (PC). MASLD metabolomic studies had been performed in mice, rats, hamsters, cows, geese, blunt snout breams, zebrafish, and humans, with the biomarker groups in agreement between experimental and clinical investigations being energy metabolites, essential and nonessential amino acids, fatty acids, and bile acids, which lay the foundation of the five metabolomic hallmarks of MASLD. Furthermore, the experimental group had higher LPC\/PC and cholesteryl esters, and the clinical group had elevated acylcarnitines, lysophosphatidylethanolamines\/phosphatidylethanolamines (LPE\/PE), triglycerides\/diglycerides, and gut microbiota metabolites. These metabolomic hallmarks aid in the understanding of the metabolic role played by obesity in MASLD development, inform mechanistic studies into underlying disease pathogenesis, and are critical for new metabolite-inspired therapies.<\/jats:p>","DOI":"10.3390\/ijms252312809","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T07:28:01Z","timestamp":1732778881000},"page":"12809","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Metabolomic Hallmarks of Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9882-5841","authenticated-orcid":false,"given":"Diren","family":"Beyo\u011flu","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical and Administrative Sciences, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA 01119, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7973-942X","authenticated-orcid":false,"given":"Yury V.","family":"Popov","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-1520","authenticated-orcid":false,"given":"Jeffrey R.","family":"Idle","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Administrative Sciences, College of Pharmacy and Health Sciences, Western New England University, Springfield, MA 01119, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: How to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J. Methodol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_5","first-page":"1097","article-title":"Molecular mechanisms in MASLD\/MASH-related HCC","volume":"10","author":"Wang","year":"2024","journal-title":"Hepatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Jarvis, H., Craig, D., Barker, R., Spiers, G., Stow, D., Anstee, Q.M., and Hanratty, B. (2020). Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003100"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e3230","DOI":"10.1210\/clinem\/dgac292","article-title":"Serum Thrombospondin-2 Levels Are Closely Associated With the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease","volume":"107","author":"Wu","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.dld.2021.12.002","article-title":"Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk","volume":"54","author":"Nasereldin","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Alkhouri, N., Almomani, A., Le, P., Payne, J.Y., Asaad, I., Polanco, P., Leff, P., Kumar, P., and Noureddin, M. (2024). The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)-related advanced fibrosis and cirrhosis in the United States population utilizing AGILE 3 + and AGILE 4 scores: Analysis of the NHANES 2017-2018 cycle. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03295-8"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/labinvest.2015.95","article-title":"Pivotal role of liver sinusoidal endothelial cells in NAFLD\/NASH progression","volume":"95","author":"Miyao","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Adams, J.C., and Lawler, J. (2011). The thrombospondins. Cold Spring Harb. Perspect. Biol., 3.","DOI":"10.1101\/cshperspect.a009712"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","article-title":"Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance","volume":"79","author":"Hutchison","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","article-title":"Urea cycle dysregulation in non-alcoholic fatty liver disease","volume":"69","author":"Heeboll","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"155952","DOI":"10.1016\/j.metabol.2024.155952","article-title":"The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis","volume":"158","author":"Kerbert","year":"2024","journal-title":"Metabolism"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Avila-Calderon, E.D., Ruiz-Palma, M.D.S., Aguilera-Arreola, M.G., Velazquez-Guadarrama, N., Ruiz, E.A., Gomez-Lunar, Z., Witonsky, S., and Contreras-Rodriguez, A. (2021). Outer Membrane Vesicles of Gram-Negative Bacteria: An Outlook on Biogenesis. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.557902"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Vaure, C., and Liu, Y. (2014). A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00316"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-3-21","article-title":"Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis","volume":"3","author":"Guo","year":"2010","journal-title":"Fibrogenesis Tissue Repair."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","article-title":"A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARalpha and PCK1","volume":"36","author":"Gallage","year":"2024","journal-title":"Cell Metab."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Beyoglu, D., Popov, Y.V., and Idle, J.R. (2024). The Metabolomic Footprint of Liver Fibrosis. Cells, 13.","DOI":"10.3390\/cells13161333"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1158\/0008-5472.CAN-11-0885","article-title":"Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling","volume":"71","author":"Patterson","year":"2011","journal-title":"Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jss.2012.08.011","article-title":"Metabolomic markers for intestinal ischemia in a mouse model","volume":"178","author":"Fahrner","year":"2012","journal-title":"J. Surg. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyoglu","year":"2013","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1194\/jlr.M050682","article-title":"Disruption of tumor suppressor gene Hint1 leads to remodeling of the lipid metabolic phenotype of mouse liver","volume":"55","author":"Beyoglu","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jvh.12376","article-title":"Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection","volume":"22","author":"Semmo","year":"2015","journal-title":"J. Viral Hepat."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1624","DOI":"10.7717\/peerj.1624","article-title":"The metabolomic profile of gamma-irradiated human hepatoma and muscle cells reveals metabolic changes consistent with the Warburg effect","volume":"4","author":"Wang","year":"2016","journal-title":"PeerJ"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Simillion, C., Semmo, N., Idle, J.R., and Beyoglu, D. (2017). Robust Regression Analysis of GCMS Data Reveals Differential Rewiring of Metabolic Networks in Hepatitis B and C Patients. Metabolites, 7.","DOI":"10.3390\/metabo7040051"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Keogh, A., Senkardes, S., Idle, J.R., Kucukguzel, S.G., and Beyoglu, D. (2017). A Novel Anti-Hepatitis C Virus and Antiproliferative Agent Alters Metabolic Networks in HepG2 and Hep3B Cells. Metabolites, 7.","DOI":"10.3390\/metabo7020023"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Patel, D.P., Krausz, K.W., Xie, C., Beyoglu, D., Gonzalez, F.J., and Idle, J.R. (2017). Metabolic profiling by gas chromatography-mass spectrometry of energy metabolism in high-fat diet-fed obese mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177953"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1667\/RR14592.1","article-title":"Metabolomic Analysis of Mice Exposed to Gamma Radiation Reveals a Systemic Understanding of Total-Body Exposure","volume":"187","author":"Golla","year":"2017","journal-title":"Radiat. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbacli.2017.03.002","article-title":"The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features","volume":"7","author":"Pabst","year":"2017","journal-title":"BBA Clin."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Idle, J.R., Seipel, K., Bacher, U., Pabst, T., and Beyoglu, D. (2020). (2R,3S)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia. Cancers, 12.","DOI":"10.3390\/cancers12102842"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8489","DOI":"10.1039\/D2FO00961G","article-title":"Addition of grapes to both a standard and a high-fat Western pattern diet modifies hepatic and urinary metabolite profiles in the mouse","volume":"13","author":"Beyoglu","year":"2022","journal-title":"Food Funct."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Beyoglu, D., Simillion, C., Storni, F., De Gottardi, A., and Idle, J.R. (2022). A Metabolomic Analysis of Cirrhotic Ascites. Molecules, 27.","DOI":"10.3390\/molecules27123935"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Beyoglu, D., Huang, P., Skelton-Badlani, D., Zong, C., Popov, Y.V., and Idle, J.R. (2023). Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis. Cells, 12.","DOI":"10.3390\/cells12030485"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Beyoglu, D., Schwalm, S., Semmo, N., Huwiler, A., and Idle, J.R. (2023). Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021407"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/ijc.34229","article-title":"Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts","volume":"151","author":"Hang","year":"2022","journal-title":"Int. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: Beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Statist. Soc. B"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1467-9868.2010.00746.x","article-title":"Discovering the false discovery rate","volume":"72","author":"Benjamini","year":"2010","journal-title":"J. R. Statist. Soc. B"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1034\/j.1600-0706.2003.12010.x","article-title":"Arguments for rejecting the sequential Bonferroni in ecological studies","volume":"100","author":"Moran","year":"2003","journal-title":"Oikos"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/beheco\/arh107","article-title":"A farewell to Bonferroni: The problems of low statistical power and publication bias","volume":"15","author":"Nakagawa","year":"2004","journal-title":"Behav. Ecol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yun, J.H., Kim, J.M., Jeon, H.J., Oh, T., Choi, H.J., and Kim, B.J. (2020). Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0241365"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Li, L.J., Wang, X., Chong, Y.S., Chan, J.K.Y., Tan, K.H., Eriksson, J.G., Huang, Z., Rahman, M.L., Cui, L., and Zhang, C. (2023). Exploring preconception signatures of metabolites in mothers with gestational diabetes mellitus using a non-targeted approach. BMC Med., 21.","DOI":"10.1186\/s12916-023-02819-5"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Yang, M., Zhu, C., Du, L., Huang, J., Lu, J., Yang, J., Tong, Y., Zhu, M., Song, C., and Shen, C. (2023). A Metabolomic Signature of Obesity and Risk of Colorectal Cancer: Two Nested Case-Control Studies. Metabolites, 13.","DOI":"10.3390\/metabo13020234"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41531-024-00713-2","article-title":"Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson\u2019s disease","volume":"10","author":"Hu","year":"2024","journal-title":"NPJ Park. Dis."},{"key":"ref_50","unstructured":"Harrell, F.E. (2010). Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis, Springer."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/bib\/bbl008","article-title":"Metabolomics Standards Workshop and the development of international standards for reporting metabolomics experimental results","volume":"7","author":"Castle","year":"2006","journal-title":"Brief. Bioinform."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nbt0807-846b","article-title":"The metabolomics standards initiative","volume":"25","author":"Members","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"170138","DOI":"10.1038\/sdata.2017.138","article-title":"A decade after the metabolomics standards initiative it\u2019s time for a revision","volume":"4","author":"Spicer","year":"2017","journal-title":"Sci. Data"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1021\/acs.analchem.7b02162","article-title":"Biologically Consistent Annotation of Metabolomics Data","volume":"89","author":"Alden","year":"2017","journal-title":"Anal. Chem."},{"key":"ref_56","first-page":"113","article-title":"Multi-omics approaches for precision obesity management: Potentials and limitations of omics in precision prevention, treatment and risk reduction of obesity","volume":"135","author":"Woldemariam","year":"2023","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e15226","DOI":"10.1111\/dme.15226","article-title":"Identifying obesity subtypes: A review of studies utilising clinical biomarkers and genetic data","volume":"40","author":"Abraham","year":"2023","journal-title":"Diabet. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"eadh9940","DOI":"10.1126\/scitranslmed.adh9940","article-title":"Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population","volume":"16","author":"Ding","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Beyoglu, D., and Idle, J.R. (2020). Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites, 10.","DOI":"10.3390\/metabo10020050"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-14-0109","article-title":"Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer","volume":"74","author":"Mathe","year":"2014","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3350\/cmh.2021.0127","article-title":"Recent advances in nonalcoholic fatty liver disease metabolomics","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.3350\/cmh.2022.0348","article-title":"Noninvasive serum biomarkers for liver fibrosis in NAFLD: Current and future","volume":"29","author":"Reinson","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.3350\/cmh.2022.0426","article-title":"Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: Present and future","volume":"29","author":"Yip","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2217\/14622416.7.7.1095","article-title":"Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders","volume":"7","author":"Griffin","year":"2006","journal-title":"Pharmacogenomics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2217\/17520363.1.4.575","article-title":"Applications of metabolomics to understanding obesity in mouse and man","volume":"1","author":"Gulston","year":"2007","journal-title":"Biomark. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2005.07.009","article-title":"Metabolic profiling of livers and blood from obese Zucker rats","volume":"44","author":"Serkova","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/rcm.3640","article-title":"Profiling and biomarker identification in plasma from different Zucker rat strains via high mass accuracy multistage mass spectrometric analysis using liquid chromatography\/mass spectrometry with a quadrupole ion trap-time of flight mass spectrometer","volume":"22","author":"Loftus","year":"2008","journal-title":"Rapid Commun. Mass. Spectrom."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/pr100892r","article-title":"Metabolomic analysis of livers and serum from high-fat diet induced obese mice","volume":"10","author":"Kim","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1152\/japplphysiol.00701.2010","article-title":"Metabolomic response to exercise training in lean and diet-induced obese mice","volume":"110","author":"Duggan","year":"2011","journal-title":"J. Appl. Physiol. (1985)"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/aps.2010.196","article-title":"GC-TOF\/MS-based metabolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats","volume":"32","author":"Ma","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1463-1326.2011.01410.x","article-title":"Differentiating short- and long-term effects of diet in the obese mouse using (1) H-nuclear magnetic resonance metabolomics","volume":"13","author":"Duggan","year":"2011","journal-title":"Diabetes Obes. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1021\/pr2005555","article-title":"Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes","volume":"10","author":"Oberbach","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2337\/DC11-1577","article-title":"Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: Evidence for enhanced mitochondrial oxidation","volume":"35","author":"Mihalik","year":"2012","journal-title":"Diabetes Care"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1373\/clinchem.2011.176396","article-title":"Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: Plasma metabolomic approach using GC-MS","volume":"58","author":"Samino","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Sampey, B.P., Freemerman, A.J., Zhang, J., Kuan, P.F., Galanko, J.A., O\u2019Connell, T.M., Ilkayeva, O.R., Muehlbauer, M.J., Stevens, R.D., and Newgard, C.B. (2012). Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038812"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1089\/omi.2012.0062","article-title":"Gender-dependent associations of metabolite profiles and body fat distribution in a healthy population with central obesity: Towards metabolomics diagnostics","volume":"16","author":"Szymanska","year":"2012","journal-title":"OMICS"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Won, E.Y., Yoon, M.K., Kim, S.W., Jung, Y., Bae, H.W., Lee, D., Park, S.G., Lee, C.H., Hwang, G.S., and Chi, S.W. (2013). Gender-specific metabolomic profiling of obesity in leptin-deficient ob\/ob mice by 1H NMR spectroscopy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075998"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/oby.20901","article-title":"Metabolomic profiles and childhood obesity","volume":"22","author":"Perng","year":"2014","journal-title":"Obesity"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/MCG.0000000000000236","article-title":"Application of NMR-based metabolomics to the study of gut microbiota in obesity","volume":"48","author":"Calvani","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.diabres.2015.01.014","article-title":"Targeted metabolomic analysis reveals the association between the postprandial change in palmitic acid, branched-chain amino acids and insulin resistance in young obese subjects","volume":"108","author":"Liu","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/oby.21046","article-title":"Metabolomic analysis reveals altered skeletal muscle amino acid and fatty acid handling in obese humans","volume":"23","author":"Baker","year":"2015","journal-title":"Obesity"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/bmc.3491","article-title":"Metabolomic analysis of serum from obese adults with hyperlipemia by UHPLC-Q-TOF MS\/MS","volume":"30","author":"Wang","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3945\/ajcn.115.111872","article-title":"Global metabolomic profiling targeting childhood obesity in the Hispanic population","volume":"102","author":"Butte","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Badoud, F., Lam, K.P., Perreault, M., Zulyniak, M.A., Britz-McKibbin, P., and Mutch, D.M. (2015). Metabolomics Reveals Metabolically Healthy and Unhealthy Obese Individuals Differ in their Response to a Caloric Challenge. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134613"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00216-015-9133-0","article-title":"Metabolomic profiling of urinary changes in mice with monosodium glutamate-induced obesity","volume":"408","author":"Pelantova","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3945\/ajcn.115.110536","article-title":"Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner","volume":"102","author":"Gralka","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_87","first-page":"2391592","article-title":"An Investigation into the Antiobesity Effects of Morinda citrifolia L. Leaf Extract in High Fat Diet Induced Obese Rats Using a (1)H NMR Metabolomics Approach","volume":"2016","author":"Saari","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ijpo.12114","article-title":"Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents","volume":"12","author":"Cho","year":"2017","journal-title":"Pediatr. Obes."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ijo.2016.92","article-title":"Insulin resistance in prepubertal obese children correlates with sex-dependent early onset metabolomic alterations","volume":"40","author":"Mastrangelo","year":"2016","journal-title":"Int. J. Obes."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jep.2016.10.022","article-title":"Biochemical studies of Piper betle L leaf extract on obese treated animal using 1H-NMR-based metabolomic approach of blood serum samples","volume":"194","author":"Husin","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jpba.2016.10.012","article-title":"Urine metabolomics of high-fat diet induced obesity using UHPLC-Q-TOF-MS","volume":"132","author":"Men","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cca.2016.10.005","article-title":"Biomarkers of Morbid Obesity and Prediabetes by Metabolomic Profiling of Human Discordant Phenotypes","volume":"463","author":"Tulipani","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Troisi, J., Pierri, L., Landolfi, A., Marciano, F., Bisogno, A., Belmonte, F., Palladino, C., Guercio Nuzio, S., Campiglia, P., and Vajro, P. (2017). Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways\/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. Nutrients, 9.","DOI":"10.3390\/nu9050485"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.placenta.2017.11.014","article-title":"Preliminary metabolomics analysis of placenta in maternal obesity","volume":"61","author":"Fattuoni","year":"2018","journal-title":"Placenta"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1021\/acs.jproteome.7b00802","article-title":"Obesity-Related Metabolomic Profiles and Discrimination of Metabolically Unhealthy Obesity","volume":"17","author":"Bagheri","year":"2018","journal-title":"J. Proteome Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"FSO310","DOI":"10.4155\/fsoa-2017-0146","article-title":"Identification of metabolic phenotypes in childhood obesity by (1)H NMR metabolomics of blood plasma","volume":"4","author":"Bervoets","year":"2018","journal-title":"Future Sci. OA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e5410","DOI":"10.7717\/peerj.5410","article-title":"Metabolomic analysis of obesity, metabolic syndrome, and type 2 diabetes: Amino acid and acylcarnitine levels change along a spectrum of metabolic wellness","volume":"6","author":"Libert","year":"2018","journal-title":"PeerJ"},{"key":"ref_98","first-page":"1067","article-title":"Untargeted metabolomics approach (UPLC-Q-TOF-MS) explores the biomarkers of serum and urine in overweight\/obese young men","volume":"27","author":"Yu","year":"2018","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12944-019-1037-0","article-title":"Plasma metabolomic profiling of amino acids and polar lipids in Iranian obese adults","volume":"18","author":"Bagheri","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/jmf.2018.4310","article-title":"Metabolomics Associated with Genome-Wide Association Study Related to the Basal Metabolic Rate in Overweight\/Obese Korean Women","volume":"22","author":"Kim","year":"2019","journal-title":"J. Med. Food"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/oby.22654","article-title":"Plasma High-Resolution Metabolomics Differentiates Adults with Normal Weight Obesity from Lean Individuals","volume":"27","author":"Bellissimo","year":"2019","journal-title":"Obesity"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lokhov, P.G., Balashova, E.E., Trifonova, O.P., Maslov, D.L., Ponomarenko, E.A., and Archakov, A.I. (2020). Mass Spectrometry-Based Metabolomics Analysis of Obese Patients\u2019 Blood Plasma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020568"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"7154738","DOI":"10.1155\/2020\/7154738","article-title":"Metabolomic Links between Sugar-Sweetened Beverage Intake and Obesity","volume":"2020","author":"Zhou","year":"2020","journal-title":"J. Obes."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41366-020-0603-x","article-title":"Integrating untargeted metabolomics, genetically informed causal inference, and pathway enrichment to define the obesity metabolome","volume":"44","author":"Hsu","year":"2020","journal-title":"Int. J. Obes."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Zhou, L., Ni, Z., Yu, J., Cheng, W., Cai, Z., and Yu, C. (2020). Correlation Between Fecal Metabolomics and Gut Microbiota in Obesity and Polycystic Ovary Syndrome. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00628"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1542\/peds.102.3.e29","article-title":"Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services","volume":"102","author":"Barlow","year":"1998","journal-title":"Pediatrics"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Gall, W.E., Beebe, K., Lawton, K.A., Adam, K.P., Mitchell, M.W., Nakhle, P.J., Ryals, J.A., Milburn, M.V., Nannipieri, M., and Camastra, S. (2010). alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010883"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"111916","DOI":"10.1016\/j.mad.2024.111916","article-title":"Common and distinct metabolomic markers related to immune aging in Western European and East African populations","volume":"218","author":"Bulut","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/ecco-jcc\/jjad098","article-title":"Gut Microbiome-Generated Phenylacetylglutamine from Dietary Protein is Associated with Crohn\u2019s Disease and Exacerbates Colitis in Mouse Model Possibly via Platelet Activation","volume":"17","author":"Feng","year":"2023","journal-title":"J. Crohns Colitis"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/157340310791162659","article-title":"The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease","volume":"6","author":"Sibal","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/path.6330","article-title":"Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease","volume":"264","author":"Lambertos","year":"2024","journal-title":"J. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"101068","DOI":"10.1016\/j.plipres.2020.101068","article-title":"Emerging roles of lysophospholipids in health and disease","volume":"80","author":"Tan","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1021\/pr100452b","article-title":"Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse","volume":"9","author":"Manna","year":"2010","journal-title":"J. Proteome Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1021\/pr200310s","article-title":"UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model","volume":"10","author":"Manna","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/pr501121c","article-title":"Hepatic and fecal metabolomic analysis of the effects of Lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice","volume":"14","author":"Shi","year":"2015","journal-title":"J. Proteome Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1021\/acs.jafc.5b02830","article-title":"Mass-Spectrometry-Based Serum Metabolomics of a C57BL\/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development","volume":"63","author":"Lai","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpeds.2016.01.026","article-title":"Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study","volume":"172","author":"Jin","year":"2016","journal-title":"J. Pediatr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"8495953","DOI":"10.1155\/2016\/8495953","article-title":"Untargeted Metabolomics Reveals Intervention Effects of Total Turmeric Extract in a Rat Model of Nonalcoholic Fatty Liver Disease","volume":"2016","author":"Wang","year":"2016","journal-title":"Evid. Based Complement. Alternat Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ejcn.2017.43","article-title":"Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample","volume":"71","author":"Koch","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/oby.21855","article-title":"Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model","volume":"25","author":"Han","year":"2017","journal-title":"Obesity"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3748\/wjg.v23.i15.2771","article-title":"Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease","volume":"23","author":"Dong","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Tu, L.N., Showalter, M.R., Cajka, T., Fan, S., Pillai, V.V., Fiehn, O., and Selvaraj, V. (2017). Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-05040-6"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Prisingkorn, W., Prathomya, P., Jakovlic, I., Liu, H., Zhao, Y.H., and Wang, W.M. (2017). Transcriptomics, metabolomics and histology indicate that high-carbohydrate diet negatively affects the liver health of blunt snout bream (Megalobrama amblycephala). BMC Genom., 18.","DOI":"10.1186\/s12864-017-4246-9"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Romero-Ibarguengoitia, M.E., Vadillo-Ortega, F., Caballero, A.E., Ibarra-Gonzalez, I., Herrera-Rosas, A., Serratos-Canales, M.F., Leon-Hernandez, M., Gonzalez-Chavez, A., Mummidi, S., and Duggirala, R. (2018). Family history and obesity in youth, their effect on acylcarnitine\/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193138"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep4.1188","article-title":"Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/hep4.1322","article-title":"Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans","volume":"3","author":"Yang","year":"2019","journal-title":"Hepatol. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1530\/EC-18-0536","article-title":"Steroid metabolomic signature of liver disease in nonsyndromic childhood obesity","volume":"8","author":"Gawlik","year":"2019","journal-title":"Endocr. Connect."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Cui, H., Li, Y., Cao, M., Liao, J., Liu, X., Miao, J., Fu, H., Song, R., Wen, W., and Zhang, Z. (2020). Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00858"},{"key":"ref_130","first-page":"7433","article-title":"A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease","volume":"24","author":"Chang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1039\/D0FO02123G","article-title":"Integrative transcriptomics and metabolomics explore the mechanism of kaempferol on improving nonalcoholic steatohepatitis","volume":"11","author":"Lu","year":"2020","journal-title":"Food Funct."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Zheng, T.X., Pu, S.L., Tan, P., Du, Y.C., Qian, B.L., Chen, H., Fu, W.G., and Huang, M.Z. (2020). Liver Metabolomics Reveals the Effect of Lactobacillus reuteri on Alcoholic Liver Disease. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.595382"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Zhao, M., Xing, Y., Liu, L., Fan, X., Liu, L., Geng, T., and Gong, D. (2020). GC-TOF-MS-Based Metabolomics Analyses of Liver and Intestinal Contents in the Overfed vs. Normally-Fed Geese. Animals, 10.","DOI":"10.3390\/ani10122375"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.3748\/wjg.v26.i46.7299","article-title":"Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by high-temperature-processed feed in Sprague-Dawley rats","volume":"26","author":"Xue","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3177\/jnsv.66.536","article-title":"Targeted Metabolomics Identifies Differential Serum and Liver Amino Acids Biomarkers in Rats with Alcoholic Liver Disease","volume":"66","author":"Shi","year":"2020","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11306-020-01756-1","article-title":"Untargeted metabolomics as a diagnostic tool in NAFLD: Discrimination of steatosis, steatohepatitis and cirrhosis","volume":"17","author":"Masarone","year":"2021","journal-title":"Metabolomics"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e11346","DOI":"10.7717\/peerj.11346","article-title":"Serum metabolomic profiling reveals an increase in homocitrulline in Chinese patients with nonalcoholic fatty liver disease: A retrospective study","volume":"9","author":"Yang","year":"2021","journal-title":"PeerJ"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11306-021-01810-6","article-title":"Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: Effect of PNPLA3 genotype","volume":"17","author":"Mazzini","year":"2021","journal-title":"Metabolomics"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Kordy, K., Li, F., Lee, D.J., Kinchen, J.M., Jew, M.H., La Rocque, M.E., Zabih, S., Saavedra, M., Woodward, C., and Cunningham, N.J. (2021). Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.713234"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Feng, Y., Li, H., Chen, C., Lin, H., Xu, G., Li, H., Wang, C., Chen, J., and Sun, J. (2021). Study on the Hepatoprotection of Schisandra chinensis Caulis Polysaccharides in Nonalcoholic Fatty Liver Disease in Rats Based on Metabolomics. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.727636"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1097\/TXD.0000000000001227","article-title":"Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients","volume":"7","author":"Mowry","year":"2021","journal-title":"Transplant. Direct"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmsacl.2021.10.001","article-title":"A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease","volume":"22","author":"He","year":"2021","journal-title":"J. Mass. Spectrom. Adv. Clin. Lab."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"107773","DOI":"10.1016\/j.dib.2021.107773","article-title":"Dataset for liver metabolomic profile of highland barley Monascus purpureus went extract-treated golden hamsters with nonalcoholic fatty liver disease","volume":"40","author":"Zhu","year":"2022","journal-title":"Data Brief."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Yan, X., Li, L., Liu, P., Xu, J., Wang, Z., Ding, L., and Yang, L. (2022). Targeted metabolomics profiles serum fatty acids by HFD induced non-alcoholic fatty liver in mice based on GC-MS. J. Pharm. Biomed. Anal., 211.","DOI":"10.1016\/j.jpba.2022.114620"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Charkoftaki, G., Tan, W.Y., Berrios-Carcamo, P., Orlicky, D.J., Golla, J.P., Garcia-Milian, R., Aalizadeh, R., Thomaidis, N.S., Thompson, D.C., and Vasiliou, V. (2022). Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice. Chem. Biol. Interact., 360.","DOI":"10.1016\/j.cbi.2022.109931"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2264394","DOI":"10.1155\/2022\/2264394","article-title":"Mechanical Study of Jian-Gan-Xiao-Zhi Decoction on Nonalcoholic Fatty Liver Disease Based on Integrated Network Pharmacology and Untargeted Metabolomics","volume":"2022","author":"Cao","year":"2022","journal-title":"Evid. Based Complement. Alternat Med."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Zhang, X., Liu, T., Hou, X., Hu, C., Zhang, L., Wang, S., Zhang, Q., and Shi, K. (2022). Multi-Channel Metabolomics Analysis Identifies Novel Metabolite Biomarkers for the Early Detection of Fatty Liver Disease in Dairy Cows. Cells, 11.","DOI":"10.3390\/cells11182883"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2022.12.014","article-title":"Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)","volume":"538","author":"Shao","year":"2023","journal-title":"Clin. Chim. Acta"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1080\/00365521.2023.2225667","article-title":"Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease","volume":"58","author":"Demirel","year":"2023","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"107127","DOI":"10.1016\/j.isci.2023.107127","article-title":"Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease","volume":"26","author":"Gagnon","year":"2023","journal-title":"iScience"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Garibay-Nieto, N., Pedraza-Escudero, K., Omana-Guzman, I., Garces-Hernandez, M.J., Villanueva-Ortega, E., Flores-Torres, M., Perez-Hernandez, J.L., Leon-Hernandez, M., Laresgoiti-Servitje, E., and Palacios-Gonzalez, B. (2023). Metabolomic Phenotype of Hepatic Steatosis and Fibrosis in Mexican Children Living with Obesity. Medicina, 59.","DOI":"10.3390\/medicina59101785"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.dld.2023.10.006","article-title":"Serum metabolomic analysis in cirrhotic alcohol-associated liver disease patients identified differentially altered microbial metabolites and novel potential biomarkers for disease severity","volume":"56","author":"Calzadilla","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e22151","DOI":"10.1016\/j.heliyon.2023.e22151","article-title":"Comparative analysis of the synergetic effects of Diwuyanggan prescription on high fat diet-induced non-alcoholic fatty liver disease using untargeted metabolomics","volume":"9","author":"Xu","year":"2023","journal-title":"Heliyon"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Thing, M., Werge, M.P., Kimer, N., Hetland, L.E., Rashu, E.B., Nabilou, P., Junker, A.E., Galsgaard, E.D., Bendtsen, F., and Laupsa-Borge, J. (2024). Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03129-7"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jpp\/rgae014","article-title":"Integration of pharmacodynamics and metabolomics to reveal rhubarb anthraquinone protection against nonalcoholic fatty liver disease rat model","volume":"76","author":"Zhang","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Zhang, Y., Li, J., Han, Y., Wang, L., Zhang, Y., Geng, H., Zheng, Y., Wang, X., and Sun, C. (2024). Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries. J. Pharm. Biomed. Anal., 242.","DOI":"10.1016\/j.jpba.2024.116030"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"e0375","DOI":"10.1097\/HC9.0000000000000375","article-title":"Validation of a screening panel for pediatric metabolic dysfunction-associated steatotic liver disease using metabolomics","volume":"8","author":"Huneault","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Luo, J., Luo, M., Kaminga, A.C., Wei, J., Dai, W., Peng, Y., Zhao, K., Duan, Y., Xiao, X., and Ouyang, S. (2024). Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children. Microbiol. Spectr., 12.","DOI":"10.1128\/spectrum.05230-22"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Tang, N., Ji, L., Shi, X., Xiong, Y., Xiong, X., Zhao, H., Song, H., Wang, J., Zhang, L., and You, S. (2024). Effects of Ganjianglingzhu Decoction on Lean Non-Alcoholic Fatty Liver Disease in Mice Based on Untargeted Metabolomics. Pharmaceuticals, 17.","DOI":"10.3390\/ph17040502"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Daniels, N.J., Hershberger, C.E., Kerosky, M., Wehrle, C.J., Raj, R., Aykun, N., Allende, D.S., Aucejo, F.N., and Rotroff, D.M. (2024). Biomarker Discovery in Liver Disease Using Untargeted Metabolomics in Plasma and Saliva. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251810144"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-022-04593-3","article-title":"The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The menage a trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Hunter","year":"2022","journal-title":"Autophagy"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/pros.22489","article-title":"Autophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cells","volume":"72","author":"Kaini","year":"2012","journal-title":"Prostate"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Korbecki, J., Bosiacki, M., Kupnicka, P., Barczak, K., Zietek, P., Chlubek, D., and Baranowska-Bosiacka, I. (2024). Biochemistry and Diseases Related to the Interconversion of Phosphatidylcholine, Phosphatidylethanolamine, and Phosphatidylserine. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910745"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Sun, C., Holstein, D.J.F., Garcia-Cubero, N., Moulla, Y., Stroh, C., Dietrich, A., Schon, M.R., Gartner, D., Lohmann, T., and Dressler, M. (2023). The Role of Phosphatidylethanolamine N-Methyltransferase (PEMT) and Its Waist-Hip-Ratio-Associated Locus rs4646404 in Obesity-Related Metabolic Traits and Liver Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316850"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1096\/fj.04-3580com","article-title":"Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD)","volume":"19","author":"Song","year":"2005","journal-title":"FASEB J."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1096\/fj.201900679R","article-title":"Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance","volume":"33","author":"Wan","year":"2019","journal-title":"FASEB J."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","article-title":"Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis","volume":"152","author":"Alonso","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1096\/fj.201600646R","article-title":"Cannabinoids, inflammation, and fibrosis","volume":"30","author":"Zurier","year":"2016","journal-title":"FASEB J."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Kasatkina, L.A., Rittchen, S., and Sturm, E.M. (2021). Neuroprotective and Immunomodulatory Action of the Endocannabinoid System under Neuroinflammation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115431"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3998\/ark.5550190.0003.b18","article-title":"Reinvestigation of the tautomerism of some substituted 2-hydroxypyridines","volume":"11","author":"Forlani","year":"2002","journal-title":"ARKIVOC"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-4347(00)82770-X","article-title":"Automated pre-column high-performance liquid chromatographic method for the investigation of adibendan metabolism","volume":"490","author":"Neubert","year":"1989","journal-title":"J. Chromatogr."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/acschemneuro.5b00326","article-title":"Quantification of Histamine and Carcinine in Drosophila melanogaster Tissues","volume":"7","author":"Denno","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1073\/pnas.95.12.6744","article-title":"A 12R-lipoxygenase in human skin: Mechanistic evidence, molecular cloning, and expression","volume":"95","author":"Boeglin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.redox.2015.08.006","article-title":"The role of lipoxygenases in pathophysiology; new insights and future perspectives","volume":"6","author":"Mashima","year":"2015","journal-title":"Redox Biol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/0020-711X(83)90083-6","article-title":"Incorporation of mevalonate into squalene, lanosterol and cholesterol by different neonatal chick tissues","volume":"15","author":"Aguilera","year":"1983","journal-title":"Int. J. Biochem."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"101033","DOI":"10.1016\/j.plipres.2020.101033","article-title":"Squalene monooxygenase: A journey to the heart of cholesterol synthesis","volume":"79","author":"Chua","year":"2020","journal-title":"Prog. Lipid Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2006","journal-title":"Cell Metab."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"Kennelly","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bbamem.2013.10.018","article-title":"Phospholipid methylation in mammals: From biochemistry to physiological function","volume":"1838","author":"Vance","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_181","unstructured":"Lopez, M.J., and Mohiuddin, S.S. (2024). Biochemistry, Essential Amino Acids. StatPearls, Treasure Island (FL) ineligible companies. Disclosure: Shamim Mohiuddin declares no relevant financial relationships with ineligible companies; StatPearls Publishing."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Shen, J., Xie, E., Shen, S., Song, Z., Li, X., Wang, F., and Min, J. (2024). Essentiality of SLC7A11-Mediated Nonessential Amino Acids in MASLD. Sci. Bull., in press.","DOI":"10.1016\/j.scib.2024.09.019"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Gobeil, E., Maltais-Payette, I., Taba, N., Briere, F., Ghodsian, N., Abner, E., Bourgault, J., Gagnon, E., Manikpurage, H.D., and Couture, C. (2022). Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. Metabolites, 12.","DOI":"10.3390\/metabo12050440"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: Biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1152\/ajpendo.00336.2023","article-title":"Relationship between serum beta-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD","volume":"326","author":"Moore","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e13627","DOI":"10.1111\/eci.13627","article-title":"Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort","volume":"51","author":"Post","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1210\/clinem\/dgae028","article-title":"Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity","volume":"109","author":"Sledzinski","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"e13025","DOI":"10.1111\/obr.13025","article-title":"Comparison of methodological approaches to human gut microbiota changes in response to metabolic and bariatric surgery: A systematic review","volume":"21","author":"Hanson","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/oby.24168","article-title":"Early changes in the gut microbiota are associated with weight outcomes over 2 years following metabolic and bariatric surgery","volume":"32","author":"Steffen","year":"2024","journal-title":"Obesity"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Beyoglu, D., and Idle, J.R. (2022). The gut microbiota\u2014A vehicle for the prevention and treatment of hepatocellular carcinoma. Biochem. Pharmacol., 204.","DOI":"10.1016\/j.bcp.2022.115225"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Dave, A., Beyoglu, D., Park, E.J., Idle, J.R., and Pezzuto, J.M. (2023). Influence of grape consumption on the human microbiome. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-34813-5"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Dave, A., Park, E.J., Kumar, A., Parande, F., Beyoglu, D., Idle, J.R., and Pezzuto, J.M. (2022). Consumption of Grapes Modulates Gene Expression, Reduces Non-Alcoholic Fatty Liver Disease, and Extends Longevity in Female C57BL\/6J Mice Provided with a High-Fat Western-Pattern Diet. Foods, 11.","DOI":"10.3390\/foods11131984"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Queathem, E.D., Stagg, D.B., Nelson, A.B., Chaves, A.B., Crown, S.B., Fulghum, K., d\u2019Avignon, D.A., Ryder, J.R., Bolan, P.J., and Hayir, A. (2024). Ketogenesis protects against MASLD-MASH progression through fat oxidation-independent mechanisms. bioRxiv, 10.17.","DOI":"10.1101\/2024.10.17.618895"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"e168476","DOI":"10.1172\/jci.insight.168476","article-title":"miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression","volume":"9","author":"Cardelo","year":"2024","journal-title":"JCI Insight"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1499S","DOI":"10.3945\/ajcn.2010.28701B","article-title":"Childhood obesity and adult morbidities","volume":"91","author":"Biro","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jbt.20179","article-title":"Ontogeny of human hepatic cytochromes P450","volume":"21","author":"Hines","year":"2007","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/acs.molpharmaceut.3c01147","article-title":"Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism","volume":"21","author":"Subash","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/jcph.1493","article-title":"Characterization of the Ontogeny of Hepatic UDP-Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes","volume":"59","author":"Badee","year":"2019","journal-title":"J. Clin. Pharmacol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/12809\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:41:40Z","timestamp":1760114500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/23\/12809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":198,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["ijms252312809"],"URL":"https:\/\/doi.org\/10.3390\/ijms252312809","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]}}}